Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (601-610 of 799) with videos related to

Pageof 80
Sort By:
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Gynecologic Oncology|August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
International Journal of Cancer|July 17, 2010
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancerMaria Notaridou, Lydia Quaye, Dimitra Dafou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2012
Genome-wide association study identifies a possible susceptibility locus for endometrial cancerJirong Long, Wei Zheng, Yong-Bing Xiang, et al.
Geburtshilfe Und Frauenheilkunde|February 24, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare FacilitiesTanja Fehm, Frederik A Stübs, Martin C Koch, et al.
Journal of the National Cancer Institute|June 25, 2014
ABCA transporter gene expression and poor outcome in epithelial ovarian cancerEllen L Hedditch, Bo Gao, Amanda J Russell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association ConsortiumAlbina N Minlikeeva, Jo L Freudenheim, Kevin H Eng, et al.
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Pageof 80

Showing results (601-610 of 799) with videos related to

Sort By:
Pageof 80
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Gynecologic Oncology|August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
International Journal of Cancer|July 17, 2010
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancerMaria Notaridou, Lydia Quaye, Dimitra Dafou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2012
Genome-wide association study identifies a possible susceptibility locus for endometrial cancerJirong Long, Wei Zheng, Yong-Bing Xiang, et al.
Geburtshilfe Und Frauenheilkunde|February 24, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare FacilitiesTanja Fehm, Frederik A Stübs, Martin C Koch, et al.
Journal of the National Cancer Institute|June 25, 2014
ABCA transporter gene expression and poor outcome in epithelial ovarian cancerEllen L Hedditch, Bo Gao, Amanda J Russell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association ConsortiumAlbina N Minlikeeva, Jo L Freudenheim, Kevin H Eng, et al.
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Pageof 80